{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:12Z","timestamp":1787022432355,"version":"build-2736575974"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Blood pressure reduction in response to antihypertensive agents is less for patients with obstructive sleep apnea (OSA). Increased sympathetic and inflammatory activity, as well as alterations in the renin\u2013angiotensin\u2013aldosterone system, may play a role in this context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To address the cardiovascular mechanisms involved in response to an angiotensin II receptor antagonist, losartan, and continuous positive airway pressure (CPAP) as add-on treatment for hypertension and OSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Newly diagnosed hypertensive patients with or without OSA (allocated in a 2:1 ratio for OSA vs. no OSA) were treated with losartan 50 mg daily during a 6-week two-center, open-label, prospective, case\u2013control, parallel-design study. In the second 6-week, sex-stratified, open-label, randomized, parallel-design study, all subjects with OSA continued to receive losartan and were randomly assigned to either CPAP as add-on therapy or to no CPAP (1:1 ratio for CPAP vs. no CPAP). Study subjects without OSA were followed in parallel while they continued to take losartan. Blood samples were collected at baseline, after 6 weeks, and after 12 weeks for analysis of renin, aldosterone, noradrenaline, adrenaline, and inflammatory markers.<\/jats:p>\n                    <jats:p>Measurements and Main Results: Fifty-four patients with OSA and 35 without OSA were included in the first 6-week study. Losartan significantly increased renin levels and reduced aldosterone levels in the group without OSA. There was no significant decrease in aldosterone levels among patients with OSA. Add-on CPAP treatment tended to lower aldosterone levels, but reductions were more pronounced in measures of sympathetic activity. No significant changes in inflammatory markers were observed following treatment with losartan and CPAP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hypertensive patients with OSA responded to losartan treatment with smaller reductions in aldosterone compared with hypertensive patients without OSA. Sympathetic system activity seemed to respond primarily to add-on CPAP treatment in patients with newly discovered hypertension and OSA.<\/jats:p>\n                    <jats:p>Clinical trial registered with www.clinicaltrials.gov (NCT00701428).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201602-126oc","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T12:03:30Z","timestamp":1471867410000},"page":"2002-2011","source":"Crossref","is-referenced-by-count":14,"title":["Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9134-2107","authenticated-orcid":false,"given":"Erik","family":"Thunstr\u00f6m","sequence":"first","affiliation":[{"name":"Department of Molecular and Clinical Medicine\/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Manhem","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine\/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0129-8809","authenticated-orcid":false,"given":"T\u00fclay","family":"Yucel-Lindberg","sequence":"additional","affiliation":[{"name":"Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-6605","authenticated-orcid":false,"given":"Annika","family":"Rosengren","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine\/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-4446","authenticated-orcid":false,"given":"Caroline","family":"Lindberg","sequence":"additional","affiliation":[{"name":"Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9067-6538","authenticated-orcid":false,"given":"Y\u00fcksel","family":"Peker","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine\/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden"},{"name":"Department of Pulmonary Medicine, Faculty of Medicine, Marmara University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"2026020502572266800_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.157.1.9609063","article-title":"The prevalence of obstructive sleep apnea in hypertensives","volume":"157","author":"Worsnop","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502572266800_bib2","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","article-title":"High prevalence of unrecognized sleep apnoea in drug-resistant hypertension","volume":"19","author":"Logan","year":"2001","journal-title":"J Hypertens"},{"key":"2026020502572266800_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11325-011-0543-8","article-title":"Adherence to CPAP therapy improves quality of life and reduces symptoms among obstructive sleep apnea syndrome patients","volume":"16","author":"Avlonitou","year":"2012","journal-title":"Sleep Breath"},{"key":"2026020502572266800_bib4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/rccm.200901-0050OC","article-title":"Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea","volume":"181","author":"Barb\u00e9","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502572266800_bib5","doi-asserted-by":"crossref","first-page":"c5991","DOI":"10.1136\/bmj.c5991","article-title":"Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial","volume":"341","author":"Dur\u00e1n-Cantolla","year":"2010","journal-title":"BMJ"},{"key":"2026020502572266800_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1164\/rccm.201505-0998OC","article-title":"Blood pressure response to losartan and continuous positive airway pressure in hypertension and obstructive sleep apnea","volume":"193","author":"Thunstr\u00f6m","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502572266800_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1183\/09031936.00204209","article-title":"14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans","volume":"37","author":"Tamisier","year":"2011","journal-title":"Eur Respir J"},{"key":"2026020502572266800_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ijcard.2014.09.123","article-title":"Respective effects of OSA treatment and angiotensin receptor blocker on aldosterone in hypertensive OSA patients: a randomized cross-over controlled trial","volume":"177","author":"Lacedonia","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026020502572266800_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5664\/jcsm.27878","article-title":"Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension","volume":"6","author":"Gonzaga","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"2026020502572266800_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.smrv.2014.06.003","article-title":"Does obstructive sleep apnea cause endothelial dysfunction? A critical review of the literature","volume":"20","author":"Hoyos","year":"2015","journal-title":"Sleep Med Rev"},{"key":"2026020502572266800_bib11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1164\/rccm.201002-0162OC","article-title":"Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea","volume":"182","author":"Patt","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502572266800_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.resp.2011.03.015","article-title":"Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity","volume":"178","author":"Kent","year":"2011","journal-title":"Respir Physiol Neurobiol"},{"key":"2026020502572266800_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pcad.2008.10.005","article-title":"Obstructive sleep apnea and inflammation","volume":"51","author":"McNicholas","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"2026020502572266800_bib14","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI118235","article-title":"Sympathetic neural mechanisms in obstructive sleep apnea","volume":"96","author":"Somers","year":"1995","journal-title":"J Clin Invest"},{"key":"2026020502572266800_bib15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.5664\/jcsm.3070","article-title":"Serum inflammatory markers in obstructive sleep apnea: a meta-analysis","volume":"9","author":"Nadeem","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"2026020502572266800_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/sleep\/32.4.537","article-title":"Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome","volume":"32","author":"Steiropoulos","year":"2009","journal-title":"Sleep"},{"key":"2026020502572266800_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.smrv.2014.07.004","article-title":"Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials","volume":"21","author":"Jullian-Desayes","year":"2015","journal-title":"Sleep Med Rev"},{"key":"2026020502572266800_bib18","doi-asserted-by":"crossref","article-title":"Declaration of Helsinki: ethical principles for medical research involving human subjects","author":"World Medical Association (WMA)","DOI":"10.1515\/9783110208856.233"},{"key":"2026020502572266800_bib19","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"2026020502572266800_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2009.04.019","article-title":"The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries","volume":"158","author":"Teo","year":"2009","journal-title":"Am Heart J"},{"key":"2026020502572266800_bib21","doi-asserted-by":"crossref","first-page":"e84362","DOI":"10.1371\/journal.pone.0084362","article-title":"Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment","volume":"9","author":"Barcel\u00f3","year":"2014","journal-title":"PLoS One"},{"key":"2026020502572266800_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","article-title":"Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension","volume":"131","author":"Pratt-Ubunama","year":"2007","journal-title":"Chest"},{"key":"2026020502572266800_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.201403-0526OC","article-title":"Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea","volume":"190","author":"Nicholl","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502572266800_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2796.2003.01212.x","article-title":"Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea","volume":"254","author":"Meston","year":"2003","journal-title":"J Intern Med"},{"key":"2026020502572266800_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jhh.2009.96","article-title":"Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report","volume":"24","author":"Gaddam","year":"2010","journal-title":"J Hum Hypertens"},{"key":"2026020502572266800_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/HJH.0000000000000047","article-title":"Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension","volume":"32","author":"Kasai","year":"2014","journal-title":"J Hypertens"},{"key":"2026020502572266800_bib27","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/HJH.0000000000000238","article-title":"A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea","volume":"32","author":"Lloberes","year":"2014","journal-title":"J Hypertens"},{"key":"2026020502572266800_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1152\/jappl.2000.89.2.493","article-title":"Increased vasoconstrictor sensitivity in obstructive sleep apnea","volume":"89","author":"Kraiczi","year":"2000","journal-title":"J Appl Physiol (1985)"},{"key":"2026020502572266800_bib29","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1378\/chest.103.6.1763","article-title":"Augmented resting sympathetic activity in awake patients with obstructive sleep apnea","volume":"103","author":"Carlson","year":"1993","journal-title":"Chest"},{"key":"2026020502572266800_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.02.00106402","article-title":"Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study","volume":"19","author":"Elmasry","year":"2002","journal-title":"Eur Respir J"},{"key":"2026020502572266800_bib31","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.CIR.98.11.1071","article-title":"Altered cardiovascular variability in obstructive sleep apnea","volume":"98","author":"Narkiewicz","year":"1998","journal-title":"Circulation"},{"key":"2026020502572266800_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1378\/chest.07-1580","article-title":"Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing","volume":"133","author":"Maser","year":"2008","journal-title":"Chest"},{"key":"2026020502572266800_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2869.2007.00589.x","article-title":"The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea","volume":"16","author":"Phillips","year":"2007","journal-title":"J Sleep Res"},{"key":"2026020502572266800_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1152\/japplphysiol.00494.2005","article-title":"Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea","volume":"100","author":"Mills","year":"2006","journal-title":"J Appl Physiol (1985)"},{"key":"2026020502572266800_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.amjcard.2004.08.079","article-title":"Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension","volume":"95","author":"B\u00e9chir","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026020502572266800_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"2026020502572266800_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-9255-10-13","article-title":"Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis","volume":"10","author":"Baessler","year":"2013","journal-title":"J Inflamm (Lond)"},{"key":"2026020502572266800_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/13813450802307337","article-title":"Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS","volume":"114","author":"Ryan","year":"2008","journal-title":"Arch Physiol Biochem"},{"key":"2026020502572266800_bib39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5665\/sleep.4510","article-title":"Increased inflammatory activity in nonobese patients with coronary artery disease and obstructive sleep apnea","volume":"38","author":"Thunstr\u00f6m","year":"2015","journal-title":"Sleep"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/11\/2002\/66768772\/annalsats_13_11_2002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/11\/2002\/66768772\/annalsats_13_11_2002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:57:36Z","timestamp":1770278256000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/13\/11\/2002\/8449447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,1]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201602-126oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11]]},"published":{"date-parts":[[2016,11,1]]}}}